|
|
Gene Symbol |
ITLN1 |
|
Aliases |
HL-1, HL1, INTL, ITLN, LFR, hIntL, omentin |
|
Entrez Gene ID |
|
|
Gene Name |
Intelectin 1 |
|
Chromosomal Location |
1q23.3 |
|
HGNC ID |
|
|
e!Ensembl
|
Protein Information |
|
Protein Name |
Intelectin-1, ITLN-1, endothelial lectin HL-1, galactofuranose-binding lectin, intelectin 1 (galactofuranose binding), intestinal lactoferrin receptor |
|
Function |
Lectin that specifically recognizes microbial carbohydrate chains in a calcium-dependent manner (PubMed:11313366, PubMed:26148048). Binds to microbial glycans that contain a terminal acyclic 1,2-diol moiety, including beta-linked D-galactofuranose (beta-Galf), D-phosphoglycerol-modified glycans, D-glycero-D-talo-oct-2-ulosonic acid (KO) and 3-deoxy-D-manno-oct-2-ulosonic acid (KDO) (PubMed:26148048). Binds to glycans from Gram-positive and Gram-negative bacteria, including K.pneumoniae, S.pneumoniae, Y.pestis, P.mirabilis and P.vulgaris (PubMed:26148048). Does not bind human glycans (PubMed:26148048). Probably plays a role in the defense system against microorganisms (Probable). May function as adipokine that has no effect on basal glucose uptake but enhances insulin-stimulated glucose uptake in adipocytes (PubMed:16531507). Increases AKT phosphorylation in the absence and presence of insulin (PubMed:16531507). May interact with lactoferrin/LTF and increase its uptake, and may thereby play a role in iron absorption (PubMed:11747454, PubMed:23921499). |
|
|
UniProt |
|
|
PDB |
|
|
|
|
Interactions |
| |
STRING |
MINT |
IntAct |
ENSP00000222553 |
P43490 |
P43490 |
|
| |
View interactions
|
|
| |
Associated Diseases
Disease group | Disease Name | References |
Digestive System Diseases |
Crohn Disease |
|
Inflammatory Bowel Diseases |
|
Endocrine System Diseases |
Diabetes Mellitus |
|
PCOS |
|
Neoplasms |
Mesothelioma |
|
Multiple Sclerosis |
|
Respiratory Tract Diseases |
Asthma |
|
|
References |
|
|
|
PubMed ID |
Associated gene/s |
Associated condition |
Genetic Mutation |
Diagnostic Criteria |
Association with PCOS |
Ethnicity |
Conclusion |
|
RARRES2(chemerin) |
PCOS, insulin resistance (IR), Type 2 Diabetes |
|
Rotterdam criteria |
Related
|
81 lean and obese women with PCOS, 61 lean and obese controls |
Fat mass seems to be the main determinant factor of increased chemerin and decreased omentin in women with PCOS |
|
|
|
|
|
Direct
|
87 PCOS (obese), 72 non-PCOS women (41 obese) |
Omentin-1 level was significantly lower in the PCOS compared with the non-PCOS group, and not related to body mass |
|
|
|
|
|
Related
|
|
Decreased plasma omentin-1 levels was observed in women with PCOS, compared with control subjects, there was significantly lower levels of omentin-1 mRNA and protein in omental adipose tissue of women with PCOS |
|
|
|